Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic and Molecular Basis of Heterogeneous NK Cell Responses against Acute Leukemia.
Makanga DR, Da Rin de Lorenzo F, David G, Willem C, Dubreuil L, Legrand N, Guillaume T, Peterlin P, Lebourgeois A, Béné MC, Garnier A, Chevallier P, Gendzekhadze K, Cesbron A, Gagne K, Clemenceau B, Retière C. Makanga DR, et al. Among authors: clemenceau b. Cancers (Basel). 2020 Jul 16;12(7):1927. doi: 10.3390/cancers12071927. Cancers (Basel). 2020. PMID: 32708751 Free PMC article.
CAR T Cell Therapy's Potential for Pediatric Brain Tumors.
Thomas P, Galopin N, Bonérandi E, Clémenceau B, Fougeray S, Birklé S. Thomas P, et al. Among authors: clemenceau b. Cancers (Basel). 2021 Oct 29;13(21):5445. doi: 10.3390/cancers13215445. Cancers (Basel). 2021. PMID: 34771608 Free PMC article. Review.
Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response.
Makanga DR, Jullien M, David G, Legrand N, Willem C, Dubreuil L, Walencik A, Touzeau C, Gastinne T, Tessoulin B, Le Gouill S, Mahé B, Gagne K, Chevallier P, Clemenceau B, Retière C. Makanga DR, et al. Among authors: clemenceau b. Oncoimmunology. 2021 Jun 14;10(1):1936392. doi: 10.1080/2162402X.2021.1936392. Oncoimmunology. 2021. PMID: 34178429 Free PMC article.
Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicity.
Ollier J, Kervarrec T, Samimi M, Benlalam H, Aumont P, Vivien R, Touzé A, Labarrière N, Vié H, Clémenceau B. Ollier J, et al. Among authors: clemenceau b. Cancer Immunol Immunother. 2018 Aug;67(8):1209-1219. doi: 10.1007/s00262-018-2176-2. Epub 2018 May 28. Cancer Immunol Immunother. 2018. PMID: 29808366 Free PMC article.
52 results